PAPER Asuni AA, Guridi M, Pankiewicz JE, Sanchez S, Sadowski MJ
SEARCH RESULTS
331008 RESULTS
PAPER McMillan CT, Avants BB, Cook P, Ungar L, Trojanowski JQ, Grossman M
The power of neuroimaging biomarkers for screening frontotemporal dementia.
Hum Brain Mapp. 2014 Sep;35(9):4827-40. Epub 2014 Mar 31 PubMed: 24687814PAPER Jefferson AL
Vascular risk factors and midlife cognition: rethinking the exposure window.
Circulation. 2014 Apr 15;129(15):1548-50. Epub 2014 Mar 31 PubMed: 24687776PAPER Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N, Arima K, Matsuda H
Concordance between (99m) Tc-ECD SPECT and (18) F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. Epub 2014 Mar 29 PubMed: 24687634PAPER Weakley A, Schmitter-Edgecombe M
Analysis of verbal fluency ability in Alzheimer's disease: the role of clustering, switching and semantic proximities.
Arch Clin Neuropsychol. 2014 May;29(3):256-68. Epub 2014 Mar 30 PubMed: 24687588PAPER Parent MA, Hottman DA, Cheng S, Zhang W, McMahon LL, Yuan LL, Li L
Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.
Cell Mol Neurobiol. 2014 Jul;34(5):693-705. Epub 2014 Apr 1 PubMed: 24687455PAPER Sogawa K, Minoura K, In Y, Ishida T, Taniguchi T, Tomoo K
CH-π interaction in VQIVYK sequence elucidated by NMR spectroscopy is essential for PHF formation of tau.
Biopolymers. 2014 May;102(3):288-95. PubMed: 24687309PAPER Schneider AL, Rawlings AM, Sharrett AR, Alonso A, Mosley TH, Hoogeveen RC, Ballantyne CM, Gottesman RF, Selvin E
High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.
Eur Heart J. 2014 Jul 14;35(27):1817-24. Epub 2014 Mar 30 PubMed: 24685712PAPER
Upcoming meetings related to Alzheimer's disease.
J Alzheimers Dis. 2014 Jan 1;40(2) PubMed: 24685656PAPER
Circadian misalignment and sleep disruption in mild cognitive impairment.
J Alzheimers Dis. 2014 Jan 1;40(2) PubMed: 24685655PAPER Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP
Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):819-33. PubMed: 24685637PAPER Wilhelmus MM, de Jager M, Bakker EN, Drukarch B
Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
J Alzheimers Dis. 2014 Jan 1;42:S289-303. PubMed: 24685636PAPER Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, Li R, Shen Y
Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):877-86. PubMed: 24685635PAPER Shih YH, Tsai KJ, Lee CW, Shiesh SC, Chen WT, Pai MC, Kuo YM
Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):855-65. PubMed: 24685634PAPER Cadena-del-Castillo C, Valdes-Quezada C, Carmona-Aldana F, Arias C, Bermúdez-Rattoni F, Recillas-Targa F
Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
J Alzheimers Dis. 2014;41(3):845-54. PubMed: 24685633Current Filters
No filters selected